Tanvex BioPharma Inc
TWSE:6541
Shareholder Yield
Current shareholder yield for 
Tanvex BioPharma Inc is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Tanvex BioPharma Inc
| Average Annual Return | 8.07% |
| Standard Deviation of Annual Returns | 52.3% |
| Max Drawdown | -69% |
| Market Capitalization | 11.9B TWD |
| Shares Outstanding | 264 960 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Tanvex BioPharma Inc's latest stock split occurred on Mar 27, 2023
The company executed a 703-for-689 stock split, meaning that for every 689 shares held, investors received 703 new shares.
Before the split, Tanvex BioPharma Inc traded at 92.2261 per share. Afterward, the share price was about 91.5.
The adjusted shares began trading on Mar 27, 2023. This was Tanvex BioPharma Inc's 7th stock split, following the previous one in Mar 2, 2023.
